Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Digital Health

Social distancing may be necessary for two years or more. Here's where remote care comes into play.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

The recent rise of custom-made drugs is already redefining the state of regulation, society, and the economy.

Researcher, PreScouter

In our rearview mirror is a ten-year stretch of experimentation. What looms ahead is the rewriting of healthcare's rules.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

It's time to get comfortable with being uncomfortable.

Partner, Health & Life Sciences, Oliver Wyman

How to ensure medications work as intended for different patient populations.

Chief Executive Officer, Aetion
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

A series of perspectives on the state of data in healthcare.

Some of our 2018 predictions on consolidation, pharma, and investment came true, while others were less predictable.

Principal, Health & Life Sciences, Oliver Wyman

Once J.P. Morgan Healthcare Week comes to a close, companies will need to show as much as they tell.

Chief Strategist, Health Practice, Edelman

The key to measurement-based digital mental healthcare intervention and assessment? A patient's smartphone.

Some of our 2017 healthcare predictions on value-based care, consumers, mergers, startups, and pharma came true, while others were less predictable.

Principal, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe